Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
Bellone S, Roque DM, Siegel ER, Buza N, Hui P, Bonazzoli E, Guglielmi A, Zammataro L, Nagarkatti N, Zaidi S, Lee J, Silasi DA, Huang GS, Andikyan V, Damast S, Clark M, Azodi M, Schwartz PE, Tymon-Rosario JR, Harold JA, Mauricio D, Zeybek B, Menderes G, Altwerger G, Ratner E, Alexandrov LB, Iwasaki A, Kong Y, Song E, Dong W, Elvin JA, Choi J, Santin AD. Bellone S, et al. Among authors: damast s. Cancer. 2022 Mar 15;128(6):1206-1218. doi: 10.1002/cncr.34025. Epub 2021 Dec 7. Cancer. 2022. PMID: 34875107 Free PMC article. Clinical Trial.
Recent Key Studies in Cancers of the Uterine Corpus and Cervix: New Updates in Immunotherapy, the Microbiome, Bone Density, Quantifying Lymphovascular Invasion, and Hypofractionated Pelvic Radiation Therapy.
Harkenrider M, Fields E, Chopra S, Damast S, Kidd EA, Chino J. Harkenrider M, et al. Among authors: damast s. Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):269-275. doi: 10.1016/j.ijrobp.2022.07.1833. Int J Radiat Oncol Biol Phys. 2023. PMID: 36621226 No abstract available.
Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.
Young MR, Higgins SA, Ratner E, Yu JB, Mani S, Silasi DA, Azodi M, Rutherford T, Schwartz PE, Damast S. Young MR, et al. Among authors: damast s. Int J Gynecol Cancer. 2015 Mar;25(3):431-9. doi: 10.1097/IGC.0000000000000376. Int J Gynecol Cancer. 2015. PMID: 25621409 Free PMC article.
Factors Predictive of Improved Survival in Patients With Brain Metastases From Gynecologic Cancer: A Single Institution Retrospective Study of 47 Cases and Review of the Literature.
Gressel GM, Lundsberg LS, Altwerger G, Katchi T, Azodi M, Schwartz PE, Ratner ES, Damast S. Gressel GM, et al. Among authors: damast s. Int J Gynecol Cancer. 2015 Nov;25(9):1711-6. doi: 10.1097/IGC.0000000000000554. Int J Gynecol Cancer. 2015. PMID: 26332394 Free PMC article. Review.
Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.
Lester-Coll NH, Young MR, Park HS, Ratner ES, Litkouhi B, Damast S. Lester-Coll NH, et al. Among authors: damast s. Int J Gynecol Cancer. 2017 Nov;27(9):1904-1911. doi: 10.1097/IGC.0000000000001095. Int J Gynecol Cancer. 2017. PMID: 28763364
55 results